series-a
Stage
1
Investors
About
Develops biomarker tests to inform cancer treatment decision-making and help guide therapy selection for oncology patients.
Explore Oxford Cancer Biomarkers's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.